Davis Polk advised the joint bookrunners on the Rule 144A/Regulation S follow-on primary offering of common shares of CCR S.A. for a total of approximately R$4.1 billion (approximately $1.3…
Davis Polk is advising CSX Corporation in connection with a special meeting of shareholders, called by CSX’s board of directors, to seek shareholder guidance on certain requests of Mantle…
Davis Polk advised ContourGlobal Power Holdings S.A., an indirect wholly owned subsidiary of ContourGlobal L.P., in connection with the offering of an additional €100 million aggregate…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Microchip Technology Incorporated of $1.8 billion aggregate principal amount of…
Davis Polk advised the international joint lead managers in connection with Industrial & Infrastructure Fund Investment Corporation’s global offering of its investment units. …
Davis Polk advised the sole underwriter on the $679.9 million SEC-registered offering by Cliffs Natural Resources Inc. of 63.25 million of its common shares. The amount sold includes 8.25…
Davis Polk is advising the Special Committee of Independent Directors of Fortress Investment Group LLC in connection with the approximately $3.3 billion acquisition of Fortress by SoftBank…
Davis Polk advised the representatives of the several underwriters in connection with the debut SEC-registered debt issuance by H.B. Fuller Company of $300 million of its 4.000% notes due…
Davis Polk advised the joint book-running managers of an SEC-registered offering by co-issuers AmeriGas Partners, L.P. and AmeriGas Finance Corp. of $525 million aggregate principal…
Davis Polk advised the joint book-running managers in connection with the $125 million public offering of common stock of Coherus BioSciences, Inc. The common stock is listed on the NASDAQ…